Bpl1357
WebRandomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine. Home; Study Search; Study Details From Other Databases; Enter your email to receive notifications about new clinical trials available near you. WebJun 27, 2024 · Universal Flu Vaccine Trial Volunteer Receives Injection Volunteer in trial of candidate universal flu vaccine BPL-1357 receives an intramuscular injection.
Bpl1357
Did you know?
WebJul 8, 2024 · The vaccine: BPL-1357 was developed by National Institute of Allergy and Infectious Diseases (NIAID) researchers. The vaccine is a “whole virus” vaccine, … WebJun 28, 2024 · The BPL-1357 candidate influenza vaccine being tested in this clinical trial performed very well in pre-clinical studies and we look forward to learning how it …
WebAug 31, 2024 · BPL-1357 contains 4 whole inactivated avian influenza viruses: A /Environment /Maryland/261/2006 H7N3, A/Mallard /Maryland/802/2007 H5N1, … WebAug 28, 2024 · BPL-1357 contains 4 whole inactivated avian influenza viruses: A /Environment /Maryland/261/2006 H7N3, A/Mallard /Maryland/802/2007 H5N1, …
WebJun 29, 2024 · In trials with both mice and ferrets, BPL-1357 suggested the tantalizing promise of a universal buffer against the flu. Mice given BPL-1357 were able to survive … WebClinical Studies Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine, NCT05027932 Natural History of Systemic and Nasal Mucosal Immunity after Influenza Vaccination in a Pediatric Population, NCT04963166
WebAug 19, 2024 · The BPL-1357 candidate influenza vaccine performed well in preclinical studies and now will be tested in people. BPL-1357 is a whole-virus vaccine made up of …
small space murphy bed ikeaWebAug 28, 2024 · Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine. National Institutes of Health Clinical Center (CC) 5 August 2024. First Received: August 28, 2024 Last Updated: August 5, 2024. Phase: Phase 1 Start Date: June 27, 2024. highway 41 interchangeWebSep 9, 2024 · It’s called BPL 1357 and the BPL refers to betaproprolactone which is used as a disinfectant to destroy the nucleic acid core of viruses. The first thing you should know is that the initial study will involve 45 participants. Wow. Now this immediately screams at me because a trial involving 45 people isn’t enough to mean diddly squat. small space mudroomWebJul 13, 2024 · The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health has outlined a strategic plan for the development of a universal influenza vaccine. 11 Making this one of its highest priorities, the NIAID budgets $220 million annually in the hopes of identifying a vaccine that is 11-13: small space murphy bed ideasWebDec 7, 2024 · A universal flu vaccine, effective against any strain of the influenza virus that can infect humans, could protect us from this peril, but progress has been slow. A novel … small space music studio ideasWebFlickr photos, groups, and tags related to the "bpl1357" Flickr tag. highway 411 georgiaWebAug 31, 2024 · 2. To further characterize the immune response induced by BPL-1357 given IM or IN through variable, diversity, and joining (VDJ) gene repertoire analysis, cytokine analysis, cytometry, transcriptomics, and assessment of T-cell responses. 3. To assess the rates of influenza disease among groups given IM or IN BPL-1357 compared to placebo. … highway 410 greenwater washington